A set of medical tests called liquid biopsies could rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample.

Learn about UT Austin's Bryan Davies and his research into how to combat antibiotic-resistant bacteria and develop new antimicrobials to fight infection.

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

What do you do when the bacteria you study that's deadly in the real world acts all mild and gentle in the lab?

Biofilms are responsible for most chronic infections and are notoriously resilient and hard to treat.